1. Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens. (12th November 2019) Authors: Kempker, R R; Mikiashvili, L; Zhao, Y; Benkeser, D; Barbakadze, K; Bablishvili, N; Avaliani, Z; Peloquin, C A; Blumberg, H M; Kipiani, M Journal: Clinical infectious diseases Issue: Volume 71:Number 9(2020) Page Start: 2336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Issue 4 (April 2020) Authors: Ahmad, N; Baghaei, P; Barkane, L; Benedetti, A; Brode, SK; Brust, JCM; Campbell, JR; Chang, VWL; Falzon, D; Guglielmetti, L; Isaakidis, P; Kempker, RR; Kipiani, M; Kuksa, L; Lan, Z; Lange, C; Laniado-Laborín, R; Nahid, P; Rodrigues, D; Singla, R Journal: Lancet Issue: Volume 8:Issue 4(2020) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗